Investigating blood sugar levels in early pregnancy and their effects on health outcomes.
Measuring Early Pregnancy Glycemia and Its Impact on Adverse Outcomes
This study is looking at how high blood sugar in early pregnancy might cause issues like needing a C-section or affecting a child's weight later on, and it's for pregnant women in Boston who want to help us understand how their blood sugar levels can impact their health and their baby's health.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10919239 on NIH RePORTER |
What this research studies
This research focuses on understanding how high blood sugar levels during early pregnancy can lead to complications such as cesarean deliveries and childhood obesity. By using advanced tools like continuous glucose monitoring, the study aims to accurately measure glycemia in pregnant women during their first trimester. The research will involve a diverse group of pregnant women in Boston, allowing for a comprehensive analysis of how early glycemic levels affect both maternal and fetal health. The goal is to establish better diagnostic criteria and identify other factors that may influence health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant women in their first trimester, particularly those at risk for hyperglycemia.
Not a fit: Patients who are not pregnant or those who are in their second or third trimester may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved screening and management of blood sugar levels in early pregnancy, potentially reducing complications for mothers and their babies.
How similar studies have performed: Previous research has shown that early intervention in managing glycemia can lead to better outcomes, suggesting that this approach may be promising.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Powe, Camille Elise — Massachusetts General Hospital
- Study coordinator: Powe, Camille Elise
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.